You are here:
Waters... noitazilaicremmoC dna tnempole
Date: 2025-06-12 06:30:01Source: People & InterviewsViews (143)
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Share to:
Note: The above content and images are collected from the internet and are for reference only. If this violates your rights, please contact us to remove it.
You May Also Like
- Young... inU fo tuo gnippord dna tnange
- He... sseccus puC dloG yratiliM dnar
- ZIIP... ?stuokaerb enca lanomroh ym la
- CD... wonK eW gnihtyrevE -- radaH tc
- Seattle’s... sesac bra niw idnetnineB s’yti
- RIpple... gnilur truoc elbarovaf rof epo
- Angel... yregrus traeh gniwollof latips
- An... HCB ta mubla 'evoL' wen setarb
- Researchers... dnalsI revuocnaV ffo selahw ie